LU83843A1 - Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent - Google Patents

Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent Download PDF

Info

Publication number
LU83843A1
LU83843A1 LU83843A LU83843A LU83843A1 LU 83843 A1 LU83843 A1 LU 83843A1 LU 83843 A LU83843 A LU 83843A LU 83843 A LU83843 A LU 83843A LU 83843 A1 LU83843 A1 LU 83843A1
Authority
LU
Luxembourg
Prior art keywords
radical
general formula
alanyl
amine function
acid
Prior art date
Application number
LU83843A
Other languages
English (en)
French (fr)
Inventor
J Bouchaudon
Rosset G Dutruc
D Farge
C James
Original Assignee
Rhone Poulence Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulence Sante filed Critical Rhone Poulence Sante
Publication of LU83843A1 publication Critical patent/LU83843A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
LU83843A 1980-12-19 1981-12-18 Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent LU83843A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8027020A FR2496654A1 (fr) 1980-12-19 1980-12-19 Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent
FR8027020 1980-12-19

Publications (1)

Publication Number Publication Date
LU83843A1 true LU83843A1 (fr) 1982-07-07

Family

ID=9249292

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83843A LU83843A1 (fr) 1980-12-19 1981-12-18 Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent

Country Status (17)

Country Link
US (1) US4401658A (sv)
JP (1) JPS57154151A (sv)
AU (1) AU555294B2 (sv)
BE (1) BE891539A (sv)
CA (1) CA1250398A (sv)
CH (1) CH653039A5 (sv)
DE (1) DE3150295A1 (sv)
DK (1) DK154436C (sv)
FR (1) FR2496654A1 (sv)
GB (1) GB2089816B (sv)
IE (1) IE52113B1 (sv)
IT (1) IT1142148B (sv)
LU (1) LU83843A1 (sv)
NL (1) NL8105587A (sv)
NZ (1) NZ199310A (sv)
SE (1) SE454699B (sv)
ZA (1) ZA818737B (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019383A (en) * 1981-01-09 1991-05-28 New York Blood Center, Inc. Fatty acid carriers for synthetic peptides
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
WO1988001613A1 (en) * 1986-08-27 1988-03-10 Pfizer Inc. Crystalline n-(s-3-methylheptanoyl)-d-gamma-glutamyl-glycyl-d-alanine, and processes and intermediates therefor
WO1988001612A1 (en) * 1986-08-27 1988-03-10 Pfizer Inc. Processes and intermediates for n-(s-3-alkyl-heptanoyl)-d-gamma-glutamyl-glycyl-d-alanine
US4874608A (en) * 1987-04-27 1989-10-17 Imreg, Inc. Therapeutic method for treating malignancies
US5721109A (en) * 1989-01-18 1998-02-24 Sawai Pharmaceutical Co., Ltd. Method for diagnosing infection caused by acid-fast bacterium
WO1990008323A1 (en) * 1989-01-18 1990-07-26 Sawai Pharmaceutical Co., Ltd. Reagent for detecting antibody corresponding to acid-fast bacterium antigen and application thereof
US5134225A (en) * 1989-02-21 1992-07-28 Pfizer Inc. Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-D-alanine
US5136020A (en) * 1989-02-21 1992-08-04 Pfizer Inc. Crystalline n-(s-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor
US5248820A (en) * 1989-02-21 1993-09-28 Pfizer Inc. Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor
US5245079A (en) * 1989-02-21 1993-09-14 Pfizer Inc. Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine
US5185464A (en) * 1989-02-21 1993-02-09 Pfizer Inc. Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor
DE9110182U1 (de) * 1991-08-17 1992-12-17 Wilhelm Koch GmbH, 4830 Gütersloh Einbauleuchte
AUPO161196A0 (en) * 1996-08-13 1996-09-05 Commonwealth Scientific And Industrial Research Organisation Novel compounds
KR101219880B1 (ko) * 2010-10-08 2013-01-08 한국생산기술연구원 나노 버블을 이용한 두부제조방법
WO2012142659A1 (en) * 2011-04-19 2012-10-26 Baker Idi Heart And Diabetes Institute Holdings Limited Site-selective modification of proteins
EP2975046A1 (en) 2014-07-16 2016-01-20 The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth Novel compounds
CN110092735B (zh) * 2018-01-31 2021-05-11 尚科生物医药（上海）有限公司 一种l-丙氨酸衍生物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
US4311640A (en) * 1978-11-14 1982-01-19 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
DE2963446D1 (en) * 1978-11-14 1982-09-16 Fujisawa Pharmaceutical Co New lactyl tetrapeptide, processes for preparation thereof and pharmaceutical compositions containing it
FR2460290A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent
FR2460289A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent

Also Published As

Publication number Publication date
DK154436C (da) 1989-04-17
IE812974L (en) 1982-06-19
DK563181A (da) 1982-06-20
SE454699B (sv) 1988-05-24
US4401658A (en) 1983-08-30
BE891539A (fr) 1982-06-18
IE52113B1 (en) 1987-06-24
SE8107634L (sv) 1982-06-20
IT8125703A0 (it) 1981-12-18
FR2496654B1 (sv) 1983-12-16
DE3150295A1 (de) 1982-07-29
FR2496654A1 (fr) 1982-06-25
IT1142148B (it) 1986-10-08
CH653039A5 (fr) 1985-12-13
JPS57154151A (en) 1982-09-22
GB2089816A (en) 1982-06-30
CA1250398A (fr) 1989-02-21
AU555294B2 (en) 1986-09-18
DK154436B (da) 1988-11-14
ZA818737B (en) 1982-11-24
AU7859081A (en) 1982-06-24
NZ199310A (en) 1985-10-11
NL8105587A (nl) 1982-07-16
JPH0337560B2 (sv) 1991-06-05
GB2089816B (en) 1984-07-18

Similar Documents

Publication Publication Date Title
LU83843A1 (fr) Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent
LU82567A1 (fr) Nouveaux tetra-ou pentapeptides,leur preparation et les medicaments qui les contiennent
JP3358827B2 (ja) Ｎ−アシル−ｓ−（２−ヒドロキシアルキル）システイン
FR2460291A1 (fr) Nouveaux tripeptides agissant sur le systeme nerveux central et leur procede de preparation
EP0122818B1 (fr) Synthèse du hpGRF (Somatocrinine) en phase liquide et peptides intermédiaires
CA1251000A (fr) Dipeptides, leur preparation et les medicaments qui les contiennent
JPS6345398B2 (sv)
LU82569A1 (fr) Nouveaux tripeptides,leur preparation et les medicaments qui les contiennent
EP0187095A1 (fr) Esters de tri- et tétrapeptides inhibiteurs de la sécrétion gastrique, procédé d'obtention et compositions pharmaceutiques les contenant
BE897844A (fr) Alkylamides de tripeptides et de tetrapeptides biologiquement actifs, procede pour leur preparation et compositions
EP0010587B1 (de) Adamantylalkyloxycarbonylderivate, deren Herstellung und Verwendung zur Darstellung von Peptiden
FR2460292A1 (fr) Nouveaux tripeptidamides actifs sur le systeme nerveux central et procede de preparation de ceux-ci
EP0124420B1 (fr) Nouveaux dérivés peptidiques inhibiteurs de la sécrétion gastrique, procédé pour leur préparation et médicaments les contenant
SE452318B (sv) Aminosyror till anvendning som mellanprodukter vid framstellning av bestatiner
EP0188947B1 (fr) Peptides réduits, inhibiteurs de la sécrétion gastrique, procédé d'obtention et compositions pharmaceutiques les contenant
EP0354108B1 (fr) Amino-acides et peptides présentant un résidu tyrosine modifiée, leur préparation et leur application comme médicaments
FR2513994A1 (fr) Tripeptides anorexigenes, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2487341A1 (fr) Tripeptides inhibiteurs de l'enzyme de transformation de l'angiotensine
PT758342E (pt) Nova substancia activa peptidica e sua preparacao
JPS60116700A (ja) キョ−トルフィン誘導体
SU1660578A3 (ru) Способ получени N-[3-(N-циклопентакарбонил-D-аланилтио)-2-D-метилпропаноил]-L-пролина
FR2482960A2 (fr) Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent
JPH0254360B2 (sv)
BE814419R (fr) (1-alpha-aminoisobutyryl)-corticotropines peptidiques
BE623243A (sv)